News New Novartis blood cancer drug approved in EU Rydapt approved in mastocytosis, related blood cancers, and AML
News FDA puts hold on AZ and Celgene immunotherapy trials Regulator is exploring safety of immunotherapy combinations in blood cancer
News FDA halts recruitment to three BMS Opdivo trials FDA is investigating safety of immunotherapies in blood cancer.
News Janssen art campaign raises awareness about blood cancer Janssen has launched a campaign to raise awareness about blood cancer, unveiling a giant art installation in London’s Paternoster Square.
News Cellectis CAR-T trials on hold after patient death Cellectis’ 'off the shelf' CAR-T cancer therapy has hit a major setback after the first patient treated in a phase 1 study died, and the first patient treated in another developed life-thr
News Chinese trial backs base-editing drug for thalassaemia A landmark study in China has shown that a base-editing therapy developed by CorrectSequence achieved stellar results in beta-thalassaemia.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
